Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Liver Diseases

  Free Subscription


05.03.2018

3 AJR Am J Roentgenol
4 Biochem Biophys Res Commun
6 BMC Cancer
1 BMC Gastroenterol
2 Cancer Res
2 Dig Dis Sci
4 Eur Radiol
14 Gut
5 Hepatology
1 Indian J Gastroenterol
1 Int J Cancer
1 J Comput Assist Tomogr
11 J Gastroenterol Hepatol
2 J Hepatol
4 N Engl J Med
5 PLoS One
4 Semin Liver Dis
4 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. SEO N, Kim DY, Choi JY
    Reply to "Radiologic Evaluation of Intrahepatic Cholangiocarcinoma Perineural Invasion".
    AJR Am J Roentgenol. 2018;210:W130.
    PubMed     Text format    

  2. RAGHAVAN K, Jeffrey RB, Olcott EW
    Radiologic Evaluation of Intrahepatic Cholangiocarcinoma Perineural Invasion.
    AJR Am J Roentgenol. 2018;210:W129.
    PubMed     Text format    

  3. POULLOS PD, Tseng JJ, Melcher ML, Concepcion W, et al
    Structured Reporting of Multiphasic CT for Hepatocellular Carcinoma: Effect on Staging and Suitability for Transplant.
    AJR Am J Roentgenol. 2018 Feb 22:1-9. doi: 10.2214/AJR.17.18725.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  4. WANG J, Yang T, Chen H, Li H, et al
    Oncogene RPA1 promotes proliferation of hepatocellular carcinoma via CDK4/Cyclin-D pathway.
    Biochem Biophys Res Commun. 2018 Feb 22. pii: S0006-291X(18)30407.
    PubMed     Text format     Abstract available

  5. OGURA N, Ogawa K, Watashi K, Ito T, et al
    Novel stable HBV producing cell line systems for expression and screening antiviral inhibitor of hepatitis B virus in human hepatoma cell line.
    Biochem Biophys Res Commun. 2018 Feb 23. pii: S0006-291X(18)30415.
    PubMed     Text format     Abstract available

  6. ZHANG X, Zhang P, Gao J, Huang Q, et al
    Autophagy dysregulation caused by ApoM deficiency plays an important role in liver lipid metabolic disorder.
    Biochem Biophys Res Commun. 2018;495:2643-2648.
    PubMed     Text format     Abstract available

  7. LIN YC, Wang FS, Yang YL, Chuang YT, et al
    MicroRNA-29a mitigation of toll-like receptor 2 and 4 signaling and alleviation of obstructive jaundice-induced fibrosis in mice.
    Biochem Biophys Res Commun. 2018;496:880-886.
    PubMed     Text format     Abstract available


    BMC Cancer

  8. QIAO Y, Yang J, Liu L, Zeng Y, et al
    Successful treatment with pazopanib plus PD-1 inhibitor and RAK cells for advanced primary hepatic angiosarcoma: a case report.
    BMC Cancer. 2018;18:212.
    PubMed     Text format     Abstract available

  9. CHEN Z, Liang W
    Myopericytoma occurrence in the liver and stomach space: imaging performance.
    BMC Cancer. 2017;17:143.
    PubMed     Text format     Abstract available

  10. PALSHOF JA, Hogdall EV, Poulsen TS, Linnemann D, et al
    Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer.
    BMC Cancer. 2017;17:48.
    PubMed     Text format     Abstract available

  11. MA MC, Chen YJ, Chiu TJ, Lan J, et al
    Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma.
    BMC Cancer. 2018;18:227.
    PubMed     Text format     Abstract available

  12. GAMBICHLER T, Strutzmann S, Tannapfel A, Susok L, et al
    Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade.
    BMC Cancer. 2017;17:327.
    PubMed     Text format     Abstract available

  13. LIU C, Li L, Lu WS, Du H, et al
    A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization.
    BMC Cancer. 2018;18:216.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  14. SENOO T, Sasaki R, Akazawa Y, Ichikawa T, et al
    Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated mice.
    BMC Gastroenterol. 2018;18:34.
    PubMed     Text format     Abstract available


    Cancer Res

  15. CAI Z, Qian ZY, Jiang H, Ma N, et al
    hPCL3s promotes hepatocellular carcinoma metastasis by activating beta-catenin signaling.
    Cancer Res. 2018 Feb 26. pii: 0008-5472.CAN-17-0028.
    PubMed     Text format     Abstract available

  16. CHENG BY, Lau EY, Leung HW, Leung CO, et al
    IRAK1 augments cancer stemness and drug resistance via the AP-1/AKR1B10 signaling cascade in hepatocellular carcinoma.
    Cancer Res. 2018 Feb 26. pii: 0008-5472.CAN-17-2445.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  17. VARDI I, Barel O, Sperber M, Schvimer M, et al
    Genetic and Structural Analysis of a SKIV2L Mutation Causing Tricho-hepato-enteric Syndrome.
    Dig Dis Sci. 2018 Feb 26. pii: 10.1007/s10620-018-4983.
    PubMed     Text format     Abstract available

  18. KOUNTOURAS J, Polyzos SA, Katsinelos P, Anastasiadis S, et al
    Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology.
    Dig Dis Sci. 2018 Feb 21. pii: 10.1007/s10620-018-4911.
    PubMed     Text format    


    Eur Radiol

  19. KIM SS, Song KD, Kim YK, Kim HC, et al
    Disappearing or residual tiny (</=5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?
    Eur Radiol. 2017;27:3088-3096.
    PubMed     Text format     Abstract available

  20. NAKAMOTO A, Tanaka Y, Juri H, Nakai G, et al
    Diagnostic performance of reduced-dose CT with a hybrid iterative reconstruction algorithm for the detection of hypervascular liver lesions: a phantom study.
    Eur Radiol. 2017;27:2995-3003.
    PubMed     Text format     Abstract available

  21. GEISEL D, Raabe P, Ludemann L, Malinowski M, et al
    Gd-EOB-DTPA-enhanced MRI for monitoring future liver remnant function after portal vein embolization and extended hemihepatectomy: A prospective trial.
    Eur Radiol. 2017;27:3080-3087.
    PubMed     Text format     Abstract available

  22. FANG J, Ma X, Yu D, Ma X, et al
    Specific imaging characteristic of solitary necrotic nodule of the liver: Marked peripheral rim-like enhancement with internal hypointensity on longer delayed MRI.
    Eur Radiol. 2017;27:3563-3573.
    PubMed     Text format     Abstract available


    Gut

  23. HEO MJ, Kim TH, You JS, Blaya D, et al
    Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression.
    Gut. 2018 Feb 23. pii: gutjnl-2017-315123. doi: 10.1136/gutjnl-2017-315123.
    PubMed     Text format     Abstract available

  24. EHLKEN H, Wroblewski R, Corpechot C, Arrive L, et al
    Spleen size for the prediction of clinical outcome in patients with primary sclerosing cholangitis.
    Gut. 2016 Feb 26. pii: gutjnl-2016-311452. doi: 10.1136/gutjnl-2016-311452.
    PubMed     Text format    

  25. AUGUSTIN S, Pons M, Genesca J
    Ruling in and ruling out with elastography in compensated advanced chronic liver disease.
    Gut. 2017;66:197-198.
    PubMed     Text format    

  26. TARGHER G
    Non-alcoholic fatty liver disease as driving force in coronary heart disease?
    Gut. 2017;66:213-214.
    PubMed     Text format    

  27. MANDORFER M, Peck-Radosavljevic M, Reiberger T
    Prevention of progression from small to large varices: are we there yet? An updated meta-analysis.
    Gut. 2017;66:1347-1349.
    PubMed     Text format    

  28. WANG S, Ding WX
    A small RNA in neutrophils protects against acute-on-chronic alcoholic liver injury.
    Gut. 2017;66:565-566.
    PubMed     Text format    

  29. CALVISI D, Eferl R
    CDK4/6 inhibition and sorafenib: a menage a deux in HCC therapy?
    Gut. 2017;66:1179-1180.
    PubMed     Text format    

  30. BERASAIN C, Lechel A
    Targeting the correct target in HCC.
    Gut. 2017;66:1352-1354.
    PubMed     Text format    

  31. MAGDALENO F, Trebicka J
    Selective LOXL2 inhibition: potent antifibrotic effects in ongoing fibrosis and fibrosis regression.
    Gut. 2017;66:1540-1541.
    PubMed     Text format    

  32. BROWN PM, Rotman Y
    What if Prometheus had steatosis? Potential use of FGF19 to promote regeneration of the fatty liver.
    Gut. 2017;66:1732-1733.
    PubMed     Text format    

  33. CONIGLIARO A, Tripodi M, Parola M
    SENP1 activity sustains cancer stem cell in hypoxic HCC.
    Gut. 2017;66:2051-2052.
    PubMed     Text format    

  34. EFERL R, Trauner M
    Chromosomal instability in HCC: a key function for checkpoint kinase 2.
    Gut. 2018;67:204-205.
    PubMed     Text format    

  35. PUENGEL T, Tacke F
    Repair macrophages in acute liver failure.
    Gut. 2018;67:202-203.
    PubMed     Text format    

  36. LUETKENS JA, Klein S, Traeber F, Schmeel FC, et al
    Quantitative liver MRI including extracellular volume fraction for non-invasive quantification of liver fibrosis: a prospective proof-of-concept study.
    Gut. 2018;67:593-594.
    PubMed     Text format    


    Hepatology

  37. FOSTER GR, Agarwal K, Cramp ME, Moreea S, et al
    Elbasvir/Grazoprevir and Sofosbuvir for HCV Genotype 3 Infection With Compensated Cirrhosis: A Randomized Trial.
    Hepatology. 2018 Feb 23. doi: 10.1002/hep.29852.
    PubMed     Text format     Abstract available

  38. HUANG AC, Mehta N, Dodge JL, Yao FY, et al
    Direct-acting Antivirals Do Not Increase the Risk of Hepatocellular Carcinoma Recurrence after Local-Regional Therapy or Liver Transplant Waitlist Dropout.
    Hepatology. 2018 Feb 24. doi: 10.1002/hep.29855.
    PubMed     Text format     Abstract available

  39. ROSENBLATT R, Brown RS Jr., Mukewar S, Schneider Y, et al
    Hepatology Highlights.
    Hepatology. 2018;67:817-819.
    PubMed     Text format    

  40. WU JF, Lee CS, Lin WH, Jeng YM, et al
    Transient elastography is useful in diagnosing biliary atresia and predicting prognosis after hepatoportoenterostomy.
    Hepatology. 2018 Feb 27. doi: 10.1002/hep.29856.
    PubMed     Text format     Abstract available

  41. HENEGHAN MA, Cannon MD
    Hepatic diagnostics in pregnancy: Biopsy, biomarkers and beyond.
    Hepatology. 2018 Feb 27. doi: 10.1002/hep.29859.
    PubMed     Text format    


    Indian J Gastroenterol

  42. YADAV SK, Choudhary NS, Saraf N, Saigal S, et al
    Nutritional status using subjective global assessment independently predicts outcome of patients waiting for living donor liver transplant.
    Indian J Gastroenterol. 2017;36:275-281.
    PubMed     Text format     Abstract available


    Int J Cancer

  43. PULTE D, Weberpals J, Schroder CC, Emrich K, et al
    Survival of patients with hepatobiliary tract and duodenal cancer sites in Germany and the United States in the early 21(st) century.
    Int J Cancer. 2018 Feb 26. doi: 10.1002/ijc.31322.
    PubMed     Text format     Abstract available


    J Comput Assist Tomogr

  44. LIU H, Imagawa D, Ward G, Dullet N, et al
    Significance and Prevalence of Haziness Surrounding the Hepatic Artery and Celiac Axis on Computed Tomographic Imaging After Pancreaticoduodenectomy.
    J Comput Assist Tomogr. 2018 Feb 27. doi: 10.1097/RCT.0000000000000714.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  45. JIA Z, Paz-Fumagalli R, Frey G, Sella DM, et al
    Single-institution experience of radioembolization with yttrium-90 microspheres for unresectable metastatic neuroendocrine liver tumors.
    J Gastroenterol Hepatol. 2017;32:1617-1623.
    PubMed     Text format     Abstract available

  46. CRESCI GA, Glueck B, McMullen MR, Xin W, et al
    Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury.
    J Gastroenterol Hepatol. 2017;32:1587-1597.
    PubMed     Text format     Abstract available

  47. PARK SW, Jun CH, Choi SK, Kim HJ, et al
    Hepatobiliary and Pancreatic: A black liver of Dubin-Johnson syndrome.
    J Gastroenterol Hepatol. 2018;33:562.
    PubMed     Text format    

  48. VANBRUGGHE C, Tabchouri N, Louis G, Del Grande J, et al
    Hepatobiliary and Pancreatic: A rare form of autoimmune pancreatitis mimicking mixed-type intraductal papillary mucinous neoplasm.
    J Gastroenterol Hepatol. 2018;33:563.
    PubMed     Text format    

  49. LIN YJ, Gao XM, Pan WW, Gao S, et al
    A model to predict the onset of non-alcoholic fatty liver disease within 2 years in elderly adults.
    J Gastroenterol Hepatol. 2017;32:1739-1745.
    PubMed     Text format     Abstract available

  50. PUIGVEHI M, Broquetas T, Coll S, Garcia-Retortillo M, et al
    Impact of anthropometric features on the applicability and accuracy of FibroScan((R)) (M and XL) in overweight/obese patients.
    J Gastroenterol Hepatol. 2017;32:1746-1753.
    PubMed     Text format     Abstract available

  51. HIROOKA M, Koizumi Y, Imai Y, Nakamura Y, et al
    Clinical utility of multipolar ablation with a 3-D simulator system for patients with liver cancer.
    J Gastroenterol Hepatol. 2017;32:1852-1858.
    PubMed     Text format     Abstract available

  52. LLOP E, Lopez M, de la Revilla J, Fernandez N, et al
    Validation of noninvasive methods to predict the presence of gastroesophageal varices in a cohort of patients with compensated advanced chronic liver disease.
    J Gastroenterol Hepatol. 2017;32:1867-1872.
    PubMed     Text format     Abstract available

  53. LV XH, Wang CH, Xie Y
    Arsenic trioxide combined with transarterial chemoembolization for primary liver cancer: A meta-analysis.
    J Gastroenterol Hepatol. 2017;32:1540-1547.
    PubMed     Text format     Abstract available

  54. ZHENG YX, Zhong X, Li YJ, Fan XG, et al
    Performance of scoring systems to predict mortality of patients with acute-on-chronic liver failure: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2017;32:1668-1678.
    PubMed     Text format     Abstract available

  55. CHOUDHURY A, Kumar M, Sharma BC, Maiwall R, et al
    Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of 'golden window': A prospective study.
    J Gastroenterol Hepatol. 2017;32:1989-1997.
    PubMed     Text format     Abstract available


    J Hepatol

  56. LYU N, Kong Y, Mu L, Lin Y, et al
    Hepatic Arterial Infusion of Oxaliplatin plus Fluorouracil/Leucovorin versus Sorafenib for Advanced Hepatocellular Carcinoma.
    J Hepatol. 2018 Feb 19. pii: S0168-8278(18)30125.
    PubMed     Text format     Abstract available

  57. SHA M, Jeong S, Xia Q
    Antiviral Therapy Improves Survival in patients with HBV infection and Intrahepatic Cholangiocarcinoma undergoing Liver Resection: Novel Concerns.
    J Hepatol. 2018 Feb 20. pii: S0168-8278(18)30122.
    PubMed     Text format    


    N Engl J Med

  58. RAHMOUNE H, Boutrid N, Bioud B
    Nonalcoholic Steatohepatitis.
    N Engl J Med. 2018;378:780-1.
    PubMed     Text format    

  59. SACHAK T, Yearsley M, Levin D
    Nonalcoholic Steatohepatitis.
    N Engl J Med. 2018;378:780.
    PubMed     Text format    

  60. ASHRAFIAN H
    Nonalcoholic Steatohepatitis.
    N Engl J Med. 2018;378:780.
    PubMed     Text format    

  61. YILDIZ H
    Nonalcoholic Steatohepatitis.
    N Engl J Med. 2018;378:779-80.
    PubMed     Text format    


    PLoS One

  62. GONG L, Huang YT, Wong CH, Chao WC, et al
    Culture-independent analysis of liver abscess using nanopore sequencing.
    PLoS One. 2018;13:e0190853.
    PubMed     Text format     Abstract available

  63. PAPACKOVA Z, Heczkova M, Dankova H, Sticova E, et al
    Silymarin prevents acetaminophen-induced hepatotoxicity in mice.
    PLoS One. 2018;13:e0191353.
    PubMed     Text format     Abstract available

  64. OTEGBEYE F, Ojo E, Moreton S, Mackowski N, et al
    Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models.
    PLoS One. 2018;13:e0191358.
    PubMed     Text format     Abstract available

  65. HE X, Wu J, Holtorf AP, Rinde H, et al
    Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China.
    PLoS One. 2018;13:e0191095.
    PubMed     Text format     Abstract available

  66. TESHIMA T, Matsumoto H, Koyama H
    Soluble factors from adipose tissue-derived mesenchymal stem cells promote canine hepatocellular carcinoma cell proliferation and invasion.
    PLoS One. 2018;13:e0191539.
    PubMed     Text format     Abstract available


    Semin Liver Dis

  67. AJMERA V, Loomba R
    Can Elastography Differentiate Isolated Fatty Liver from Nonalcoholic Steatohepatitis?
    Semin Liver Dis. 2018;38:14-20.
    PubMed     Text format     Abstract available

  68. ANDRADE RJ, Medina-Caliz I, Gonzalez-Jimenez A, Garcia-Cortes M, et al
    Hepatic Damage by Natural Remedies.
    Semin Liver Dis. 2018;38:21-40.
    PubMed     Text format     Abstract available

  69. HLADY RA, Robertson KD
    Genetic and Epigenetic Heterogeneity in Normal Liver Homeostasis and Its Implications for Liver Disease and Hepatocellular Cancer.
    Semin Liver Dis. 2018;38:41-50.
    PubMed     Text format     Abstract available

  70. TREBICKA J
    Does Transjugular Intrahepatic Portosystemic Shunt Stent Differentially Improve Survival in a Subset of Cirrhotic Patients?
    Semin Liver Dis. 2018;38:87-96.
    PubMed     Text format     Abstract available


    Transplantation

  71. STINE JG, Intagliata N, Northup PG, Caldwell SH, et al
    Nonalcoholic Fatty Liver Disease, Portal Vein Thrombosis and Coagulation: More Questions Than Answers?
    Transplantation. 2017;101:e281-e282.
    PubMed     Text format    

  72. RHU J, Kim JM, Choi GS, Kwon CHD, et al
    Validation of the alpha-fetoprotein model for hepatocellular carcinoma recurrence after transplantation in an Asian population.
    Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002136.
    PubMed     Text format     Abstract available

  73. THULUVATH AJ, Chen PH, Thuluvath PJ, Kantsevoy S, et al
    Poor Survival after Retransplantation in NASH cirrhosis.
    Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002135.
    PubMed     Text format     Abstract available

  74. GREY ST, Issa F
    The 2017 Transplantation Awards: Recognizing a Landmark Clinical Trial and a Basic Science Discovery With Far-Reaching Implications.
    Transplantation. 2017;101:2655-2656.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: